期刊
JOURNAL OF CANCER
卷 8, 期 6, 页码 1062-1070出版社
IVYSPRING INT PUBL
DOI: 10.7150/jca.17080
关键词
Esophageal neoplasias; p16; p53; immunohistochemistry; HPV
类别
资金
- CNPq [482666/2012-9]
- Fundacao de Amparo a Pequisa do Estado de Sao Paulo (FAPESP) [13/15968-0]
- INCT HPV [Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)] [08/57889-1]
- INCT HPV [Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)] [573799/2008-3]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [13/15968-0] Funding Source: FAPESP
GOAL: To investigate the HPV prevalence and characterize the expression of potential molecular surrogate markers of HPV infection in esophageal squamous cell carcinoma. MATERIALS AND METHODS: The prevalence of HPV in individuals with and without esophageal cancer (EC) was determined by using multiplex PCR; p16 and p53 protein levels were assessed by immunohistochemistry (IHC). RESULTS: High-risk HPV (hr-HPV) was found in the same frequency (13.8%) in esophageal squamous cell carcinoma (ESCC) and in healthy individuals. The p53 expression was positive in 67.5% of tumor tissue, 20.0% of adjacent non-tumoral tissue and 1.8% of normal esophageal tissue. p16 was positive in 11.6% of esophageal cancer cases and 4.7% of adjacent non-tumoral tissue. p16 was undetectable among control group samples. p53 and p16 levels were not significantly associated with the HPV status. CONCLUSIONS: These results suggest that hr-HPV types are not associated with the development of ESCC and that p53 and p16 protein expression have no relationship with HPV infection in normal or cancerous esophagus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据